IBDEI156 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20453,0)
 ;;=698.0^^131^1288^54
 ;;^UTILITY(U,$J,358.3,20453,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20453,1,4,0)
 ;;=4^698.0
 ;;^UTILITY(U,$J,358.3,20453,1,5,0)
 ;;=5^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,20453,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,20454,0)
 ;;=698.9^^131^1288^53
 ;;^UTILITY(U,$J,358.3,20454,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20454,1,4,0)
 ;;=4^698.9
 ;;^UTILITY(U,$J,358.3,20454,1,5,0)
 ;;=5^Pruritic Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,20454,2)
 ;;=^123977
 ;;^UTILITY(U,$J,358.3,20455,0)
 ;;=696.1^^131^1288^55
 ;;^UTILITY(U,$J,358.3,20455,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20455,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,20455,1,5,0)
 ;;=5^Psoriasis
 ;;^UTILITY(U,$J,358.3,20455,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,20456,0)
 ;;=287.0^^131^1288^56
 ;;^UTILITY(U,$J,358.3,20456,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20456,1,4,0)
 ;;=4^287.0
 ;;^UTILITY(U,$J,358.3,20456,1,5,0)
 ;;=5^Purpura, Vascular
 ;;^UTILITY(U,$J,358.3,20456,2)
 ;;=^101365
 ;;^UTILITY(U,$J,358.3,20457,0)
 ;;=782.1^^131^1288^57
 ;;^UTILITY(U,$J,358.3,20457,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20457,1,4,0)
 ;;=4^782.1
 ;;^UTILITY(U,$J,358.3,20457,1,5,0)
 ;;=5^Rash NOS
 ;;^UTILITY(U,$J,358.3,20457,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,20458,0)
 ;;=706.2^^131^1288^61
 ;;^UTILITY(U,$J,358.3,20458,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20458,1,4,0)
 ;;=4^706.2
 ;;^UTILITY(U,$J,358.3,20458,1,5,0)
 ;;=5^Sebaceous Cyst
 ;;^UTILITY(U,$J,358.3,20458,2)
 ;;=^41304
 ;;^UTILITY(U,$J,358.3,20459,0)
 ;;=690.10^^131^1288^64
 ;;^UTILITY(U,$J,358.3,20459,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20459,1,4,0)
 ;;=4^690.10
 ;;^UTILITY(U,$J,358.3,20459,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,20459,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,20460,0)
 ;;=702.11^^131^1288^62
 ;;^UTILITY(U,$J,358.3,20460,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20460,1,4,0)
 ;;=4^702.11
 ;;^UTILITY(U,$J,358.3,20460,1,5,0)
 ;;=5^Seborrh Keratosis, Inflammatory
 ;;^UTILITY(U,$J,358.3,20460,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,20461,0)
 ;;=702.19^^131^1288^63
 ;;^UTILITY(U,$J,358.3,20461,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20461,1,4,0)
 ;;=4^702.19
 ;;^UTILITY(U,$J,358.3,20461,1,5,0)
 ;;=5^Seborrh Keratosis, Other
 ;;^UTILITY(U,$J,358.3,20461,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,20462,0)
 ;;=686.9^^131^1288^65
 ;;^UTILITY(U,$J,358.3,20462,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20462,1,4,0)
 ;;=4^686.9
 ;;^UTILITY(U,$J,358.3,20462,1,5,0)
 ;;=5^Skin Infec, Local Unsp
 ;;^UTILITY(U,$J,358.3,20462,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,20463,0)
 ;;=708.9^^131^1288^78
 ;;^UTILITY(U,$J,358.3,20463,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20463,1,4,0)
 ;;=4^708.9
 ;;^UTILITY(U,$J,358.3,20463,1,5,0)
 ;;=5^Urticaria, Unsp
 ;;^UTILITY(U,$J,358.3,20463,2)
 ;;=^124650
 ;;^UTILITY(U,$J,358.3,20464,0)
 ;;=078.10^^131^1288^79
 ;;^UTILITY(U,$J,358.3,20464,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20464,1,4,0)
 ;;=4^078.10
 ;;^UTILITY(U,$J,358.3,20464,1,5,0)
 ;;=5^Warts
 ;;^UTILITY(U,$J,358.3,20464,2)
 ;;=^295787
 ;;^UTILITY(U,$J,358.3,20465,0)
 ;;=706.8^^131^1288^80
 ;;^UTILITY(U,$J,358.3,20465,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20465,1,4,0)
 ;;=4^706.8
 ;;^UTILITY(U,$J,358.3,20465,1,5,0)
 ;;=5^Xerosis
 ;;^UTILITY(U,$J,358.3,20465,2)
 ;;=^271931
 ;;^UTILITY(U,$J,358.3,20466,0)
 ;;=710.1^^131^1288^60
 ;;^UTILITY(U,$J,358.3,20466,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20466,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,20466,1,5,0)
 ;;=5^Scleroderma
 ;;^UTILITY(U,$J,358.3,20466,2)
 ;;=Scleroderma^108590
